Continue with FacebookLooking to list your PhD opportunities? Log in here.
We have 122 drug analysis PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
drug analysis PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
We have 122 drug analysis PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
PhD saved successfully
Development of long-acting injectable (LAI) drug delivery systems to treat ocular diseases
Delivery of drug molecules to treat visually impairing ocular diseases that originate in the posterior segment of the eye, has been the most challenging task to the pharmaceutical scientists and retinal specialists. Read more
Safer, scalable, and modifiable polymer-based lipid nanocapsules for drug delivery
Lipid nanocapsules (LNCs) are very interesting nanoformulations as they can be made by phase inversion technique (PIT), a scalable method with predictable particle size at the beginning of the preparation process. Read more
Dissecting mechanism of drug responses to novel anti-cancer therapies
Repurposing drug screens with compounds that have already gained FDA approval can accelerate the identification of new therapies to treat an illness and in the cancer setting extend life or provide compassionate care. Read more
Early predictors of drug use: using big data to understand the predictors and trajectories of drug use
Research Area. Early predictors of drug use. using big data to understand the predictors and trajectories of drug use . Scholarship Title. Read more
Sustainable and controlled drug delivery to fight global antimicrobial resistance (AMR) using hybrid porous nano containers
Research Group:
Chemistry and Biosciences
Growing antimicrobial resistance (AMR) is one of the major global challenges and it is often linked to the use of unnecessarily high doses of orally administered antibiotics following medical surgeries and infections. Read more
Design, synthesis and evaluation of novel polysialyltransferase inhibitors as anti- metastatic agents
Research Group:
Institute of Cancer Therapeutics
Polysialic acid plays an essential role in neuronal development, but by adulthood is absent from the human body. Its biosynthesis is regulated by two polysialyltransferases (polySTs). Read more
Polysialyltransferases as a target in metastatic cancer
Research Group:
Institute of Cancer Therapeutics
Polysialic acid plays an essential role in neuronal development, but by adulthood is absent from the human body. Its biosynthesis is regulated by two polysialyltransferases. Read more
In-cell quantification of drug concentrations by using advanced nano-sensor
In-cell quantification of drug concentrations is fundamentally important to drug function, efficacy and toxicity, and for understanding and accurately predicting drug interactions and inter-subject variability in drug response (either on-target or off-target effects). Read more
Dexamethasone-releasing cochlear implants for fibroblast growth inhibition
Cochlear implants are implanted electronic hearing device designed to produce useful hearing sensations to persons with severe to profound nerve deafness by electrically stimulating nerves inside the inner ear. Read more
Last chance to apply
Mathematics: Fully Funded UKRI and AstraZeneca PhD Scholarship: Computational Modelling and Optimisation of Anti-body drug conjugates for Tumours
Funding providers: UKRI Match Funded with Industry (AstraZeneca). Subject areas: Applied Mathematics, Mathematical Biology, Computational Modelling. Read more
Deep learning enabled alternative drug design for cancer patients
We invite applications from research students interested in learning and developing an understanding of deep learning-based solutions for drug design for cancer chemotherapy. Read more
Understanding the molecular basis of drug resistance in myeloid cancers
Under pathogenic challenges, cells of the innate system become epigenetically reprogrammed and establish immune memory. Read more
Advanced biomaterials for future-proof pharmaceutical formulations
While traditional, small molecule drugs continue to play a significant role due to their oral bioavailability, they also suffer from lower selectivity, frequently accompanied with side-effects. Read more
Last chance to apply
PBPK modelling of disease-drug interactions using liquid biopsy and endogenous biomarker data
Proinflammatory cytokines have been reported to suppress certain drug metabolizing enzymes (e.g., CYP3A4) both in vitro and in vivo, whereas the evidence… Read more
Developing novel formulations and materials for transmucosal drug delivery
Mucosal routes of drug administration offer numerous advantages including ease of application, non-invasive nature and sometimes possibility of targeting particular organs. Read more